食管癌放疗相关食管瘘风险预测模型的开发与验证
该研究基于两家机构2003至2017年接受放疗或放化疗的食管癌患者,采用病例对照设计(训练队列136例瘘患者与272例对照,验证队列47例与94例),识别独立风险因素并构建列线图。模型训练C指数0.805(95%CI 0.762-0.848),外部验证C指数0.764(95%CI 0.683-0.845),为个体化风险分层提供工具。
要点
- ECOG PS、BMI、T4、N2/3及再程放疗是食管瘘独立风险因素。
- 列线图预测风险训练C指数0.805,外部验证0.764。
- 该模型有助于食管癌放疗患者食管瘘的个体化风险分层。
核心结论
- 研究创建并外部验证了首个放疗相关食管瘘风险列线图,有助于食管癌患者个体化风险分层。
研究设计与样本
- 回顾性病例对照研究,纳入两家机构2003至2017年接受放疗或放化疗的食管癌患者。
- 训练队列包括136例发生食管瘘的病例和272例对照(按诊断时间、性别、婚姻、种族1:2匹配)。
- 验证队列包括47例病例和94例对照,采用bootstrap重采样进行外部验证。
主要发现
- 多变量分析显示ECOG PS、BMI、T4、N2/3和再程放疗是食管瘘的独立因素。
- 列线图预测食管瘘风险的C指数为0.805(95%CI 0.762-0.848)。
- 外部验证后C指数维持0.764(95%CI 0.683-0.845)。
关键数值与推荐
- 列线图纳入ECOG PS、BMI、T4、N2/3及再程放疗作为预测变量。
- 训练队列C指数0.805(95%CI 0.762-0.848),验证队列C指数0.764(95%CI 0.683-0.845)。
临床怎么用
- 可用于接受放疗的食管癌患者食管瘘风险个体化评估与分层。
局限性
- 回顾性设计,样本来自两家机构,外部验证采用bootstrap重采样而非完全独立队列。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We aimed to identify the risk factors and provide a nomogram for the prediction of radiotherapy-related esophageal fistula in patients with esophageal cancer (EC) using a case-control study. PATIENTS AND METHODS: Patients with esophageal fistula who received radiotherapy or chemoradiotherapy between 2003 and 2017 were retrospectively collected in two institutions. In the training cohort (TC), clinical, pathologic, and serum data of 136 patients (cases) who developed esophageal fistula during or after radiotherapy were enrolled and compared with 272 controls (1:2 matched with the diagnosis time of EC, sex, marriage, and race). After the univariable and multivariable logistic regression analyses, the independent risk factors were identified and incorporated into a nomogram. Then the nomogram for the risk prediction was externally validated in the validation cohort (VC; 47 cases and 94 controls) using bootstrap resampling. RESULTS: Multivariable analyses demonstrated that ECOG PS, BMI, T4, N2/3 and re-radiotherapy were independent factors for esophageal fistula. Then a nomogram was constructed with the C-index of 0.805 (95% CI, 0.762-0.848) for predicting the risk of developing esophageal fistula in EC patients receiving radiotherapy. Importantly, the C-index maintained 0.764 (95% CI, 0.683-0.845) after the external validation. CONCLUSIONS: We created and externally validated the first risk nomogram of esophageal fistula associated with radiotherapy. This will aid individual risk stratification of patients with EC developing esophageal fistula.
引用
- Xu Y, Wang L, He B, et al. Development and validation of a risk prediction model for radiotherapy-related esophageal fistula in esophageal cancer. Radiat Oncol. 2019. PMID: 31640802. doi:10.1186/s13014-019-1385-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。